Skip to main content
Earnings Labs
Cognition Therapeutics, Inc. logo

Cognition Therapeutics, Inc. (CGTX)

NASDAQ·Healthcare·Biotechnology

$0.68

-0.44%

Mkt Cap $66.39M

Analyst Ratings

No recent rating data.

Price Target (1 analysts)

$3.00

Range $3.00 – $3.00

Implied Upside

+338.6%

Consensus $3.00 vs current $0.68